Lower cognitive scores in the 60s tracked with higher stroke risk over 12 years
Adults in their 60s with lower performance on cognitive testing faced a higher later stroke risk in a new observational analysis published in the Journal of the American Heart Association. The signal centered on memory, overall thinking ability, and information processing speed, which rose to the top as the most informative domains in the younger older subgroup. In practical terms, the findings point toward a possible window in midlife and early older age when vascular brain injury may already be building in silence, long before a clinical stroke appears.
The cohort included 4,912 participants with no prior dementia, stroke, or transient ischemic attack, and 3,094 of them were between 60 and 69 years old. Over an average follow-up of 12.3 years, 572 participants experienced a stroke. In the 60 to 69 age group, lower overall thinking ability was tied to an 86% higher stroke risk, reduced episodic memory to a 68% higher risk, and slower processing speed to a 66% higher risk. Among all participants, lower scores on verbal fluency and selected executive function measures did not show a significant stroke association when compared with the mid-scoring group.
The age split matters because the association faded in participants 70 and older after adjustment for health and lifestyle factors, including smoking, alcohol use, physical activity, diabetes, and ischemic heart disease. One plausible interpretation is that cognitive scores in the early 60s may still capture the vascular burden of the brain before age-related noise becomes overwhelming. Once older age and accumulated comorbidity enter the picture, cognition becomes harder to separate from broader frailty, education, reserve, and nonvascular influences.
Why memory and processing speed may reveal vascular brain injury
A biological explanation fits the pattern. Memory and processing speed rely on distributed neural circuits and white-matter pathways that are especially vulnerable to small-vessel disease, microinfarcts, and other forms of silent cerebrovascular injury. When those pathways slow down or fail, the bedside cognitive footprint may emerge before a patient ever reports a focal neurologic deficit.
Lower scores in these domains may therefore be acting less like a standalone cause of stroke and more like a marker of existing vascular injury. Silent strokes, often called silent cerebral infarctions, can accumulate without the classic one-sided weakness, speech disturbance, or vision loss that usually forces urgent evaluation. Those lesions can still impair cognition and may also signal an artery network already primed for a future symptomatic event.
A vascular mechanism also fits the risk-factor profile. Hypertension, smoking, excess alcohol intake, and physical inactivity can damage cerebral blood vessels and undermine both cognition and stroke prevention at the same time. Even so, the link in the 60 to 69 group persisted after adjustment for many of these variables, which argues against a simple explanation based only on familiar risk factors. Residual vascular injury, cumulative exposure over time, or unmeasured markers of brain health may still be carrying part of the signal.
Silent strokes, shared risk factors, and the limits of screening today
Clinicians commenting on the study emphasized that silent cerebrovascular disease is a credible explanation, but not a proven one. Neuroimaging was not used to confirm whether participants with lower cognitive scores had more covert infarcts or greater small-vessel disease burden. Without MRI or another structural biomarker, the study cannot show whether the cognitive findings reflected silent strokes directly, only that the two appeared to travel together.
Shared risk factors remain central to the story. Hypertension, diabetes, smoking, and inactivity can accelerate atherosclerosis and damage both large and small cerebral vessels. A patient with lower processing speed in the early 60s may therefore be carrying a brain-level warning sign of long-standing vascular stress, even if standard risk calculators have not yet captured the full picture. Still, the study design cannot prove causality, and the cognitive signal may partly reflect the brain’s cumulative response to vascular injury rather than a predictor that adds independent power beyond existing assessments.
Current stroke risk assessment typically focuses on blood pressure, glucose, BMI, cholesterol, exercise, tobacco exposure, diet, atrial fibrillation, and personal or family history of stroke, TIA, or heart attack. The new findings raise a reasonable question about whether formal cognitive testing should eventually join that list for some patients, especially those in their 60s. For now, the answer is no. The evidence is not strong enough to make cognitive screening a routine part of stroke prediction, because the field still needs replication, proof that test scores improve prediction beyond established vascular scores, and data showing that acting on the results changes outcomes.
The most useful near-term role for cognition may be as a clue rather than a screening mandate. In a patient in the early older-adult range with vascular risk factors, lower memory or slower processing speed may justify a more careful look at blood pressure control, glycemic management, tobacco cessation, atrial fibrillation surveillance, and perhaps brain imaging if symptoms or exam findings point in that direction. The study does not justify labeling cognitive testing as a stroke-prevention tool on its own, but it does strengthen the case that brain health and vascular health are tightly linked, sometimes years before the first recognized stroke.